Childhood Amblyopia Linked to Cardiometabolic Dysfunction in Adults
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 20, 2024 -- Adults who had childhood amblyopia have greater cardiometabolic dysfunction, according to a study published online March 7 in eClinicalMedicine.
Siegfried Karl Wagner, M.D., from University College London, and colleagues conducted a cross-sectional and longitudinal analysis of 126,399 U.K. Biobank participants who underwent ocular examination to examine whether children with amblyopia have an increased risk for cardiometabolic disorders in adult life.
The researchers found that the 2,647 individuals with persisting amblyopia were more likely to be obese and have hypertension and diabetes compared with 18,481 controls without amblyopia (adjusted odds ratios, 1.16, 1.25, and 1.29, respectively). Increased risks for myocardial infarction and death were also seen in association with amblyopia (adjusted hazard ratios, 1.38 and 1.36, respectively). Amblyopic eyes had significantly increased venular caliber and increased tortuosity on retinal imaging, but had lower fractal dimension and a thinner ganglion cell-inner plexiform layer (mGC-IPL). For individuals with amblyopia, the unaffected fellow eyes had a significantly lower retinal fractal dimension and thinner mGC-IPL. Smaller optic nerve disc height and width were seen for amblyopic eyes with a persisting visual deficit compared with control eyes.
"These findings suggest generalized early life neurodevelopmental dysregulation (here captured in a common neurodevelopmental disorder) is associated with cardiometabolic conditions in later life," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older
TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.